Exeltis' Slynd

Facebook post lands Exeltis in hot water

Women's health pharma Exeltis USA has been reprimanded by the FDA for making a Facebook post that promoted its birth control product Slynd, overstating its efficacy and fa

Views & Analysis
Twitter Elon Musk the future of

Elon Musk, pharma, and the future of Twitter

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter for marketing and patients who utilise it to engage with their medical